What is it about?
We show that continuous glucose monitoring could serve as a strong alternative to the Oral Glucose Tolerance Test. It could potentially predict gestational diabetes and adverse pregnancy outcomes in the first trimester.
Featured Image
Why is it important?
Our pilot data suggests CGM's potential clinical utility in the first trimester for predicting GDM and adverse pregnancy outcomes, particularly in overweight or obese individuals. It could also potentially enhance insights into GDM pathogenesis, especially the role of glycemic variability.
Read the Original
This page is a summary of: Utilizing Continuous Glucose Monitoring for Early Detection of Gestational Diabetes and Pregnancy Outcomes in an Asian Population, Diabetes Care, September 2024, American Diabetes Association,
DOI: 10.2337/dc24-0944.
You can read the full text:
Contributors
The following have contributed to this page
